President - Psychedelic Medicine Association
CEO & Founder of Maya
David is the CEO of Maya, a real world evidence platform designed to power the ecosystem of researchers, legislators, life sciences, and insurance payors at the frontier of mental healthcare.David also directs Unlimited Sciences, a psychedelic research nonprofit combining academia with data science to understand how psychedelic healing is being conducted in the underground and surface best practices to inform psychedelic research at large.In 2019 he served as a campaign-lead in the Denver Psilocybin Initiative, helping Denver become the first US city to reform psilocybin policy.Prior, David was Co-founder & CPO at Baker Technologies, which he exited after achieving a valuation of $250MM. Leading a team of up to 100, he helped scale at 14% month-over-month to a 50% market share of SMBs in the early cannabis sector.David graduated summa cum laude in Architecture from Cambridge University and built a nonprofit to help Kenyan children access schooling. Brought up in Papua New Guinea, Portugal and Scotland, he began his career in New York with Daniel Libeskind, working on the Ground Zero masterplan.David has a decade of experience designing consumer software and his interests are behavioral data, digital art, user experience design, playing piano, and mindfulness.
Co-Founder & CEO of MINDCURE
Kelsey has over 15 years of experience founding, scaling, and operating innovative companies across Canada and the Caribbean. She has built multiple 8-figure businesses from the ground up and has twice been named Canada’s Top Female Entrepreneur. Kelsey also serves on the Entrepreneurship Council for the University of Western Ontario, where she is also a faculty member teaching Design Thinking. Kelsey holds an MBA from the Richard Ivey School of Business at the University of Western Ontario. She is an accomplished keynote speaker and published author.
Medical Director of Product and Growth at Osmind
Carlene MacMillan, MD is the Medical Director of Product and Growth at Osmind (https://www.osmind.org/), a venture-backed startup that is building a next-generation EHR for neuropsychiatry. Dr. MacMillan is an adult and child & adolescent psychiatrist; her expertise is in the treatment of refractory or severe psychiatric conditions. She founded and served as CEO of Brooklyn Minds, a large multi-specialty, multi-location mental health clinic that offers interventional psychiatry services. Dr. MacMillan was previously faculty at NYU School of Medicine, and before that received her MD at Harvard Medical School and completed residency and fellowship at MGH McLean Hospital. She has also served on the boards of various clinical societies and has consulted to several medtech startups. She has a large following on Clubhouse where psychiatrists nationwide turn to her for advice on technology and innovation.
Technology is helping clinicians achieve better outcomes with patients in so many different ways these days. From wearables that can deliver patient data wirelessly to their providers, to apps that help patients monitor their own progress, technology has found its way into many of our medical interactions.The field of psychedelic medicine is starting to see some digital applications arrive on the scene as well. From electronic medical records designed specifically at psychedelic-assisted therapy providers to patient-side applications that help them prepare for journeys, companies are exploring many different ways to help patients optimize their healing through technology.
For this month’s webinar, we wanted to take a look at how these new technologies are making an impact in their current use and hear what kinds of digital advances may be coming soon to help clinicians and patients in their journey to healing.
We are honored to have panelists on this month’s webinar to cover:
…and much more!
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.